Shengqian Xu

Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis

Mei Yang, Faming Pan, Jing Gao et al. · Clinical Rheumatology · 2010 · 228 citations

Inflammation, Rheumatology, Autoimmune Disease +10

Osteoprotegerin and RANKL in the pathogenesis of rheumatoid arthritis-induced osteoporosis

Shengqian Xu, Yu Wang, Jingqiu Lu et al. · Rheumatology International · 2011 · 105 citations

Inflammation, Rheumatology, Bone Disease +11

Prevalence and risk factors associated with vertebral osteoporotic fractures in patients with rheumatoid arthritis

Jing‐Jing Tong, Shengqian Xu, He-xiang Zong et al. · Clinical Rheumatology · 2019 · 54 citations

Bone Disease, Rheumatology, Skeletal Trauma +9

TNF Inhibitor Therapy for Rheumatoid Arthritis

Xixi Ma, Shengqian Xu · Journal of Clinical & Cellular Immunology · 2012 · 50 citations · Full text

H19 Increases IL-17A/IL-23 Releases via Regulating VDR by Interacting with miR675-5p/miR22-5p in Ankylosing Spondylitis

Xu Zhang, Shuang Ji, Guoqi Cai et al. · Molecular Therapy — Nucleic Acids · 2019 · 43 citations · Full text